You are here

Home > Topics > Technology > Benefiting Humanity

Benefiting Humanity

Technology

Yeda Technology Transfer
Benefiting Humanity
Biotechnology
Diagnostic Techniques and Drugs
perach all stars

Growing Stronger

04.02.2019
Benefiting Humanity
A dozen students receive scholarships for mentoring kids in need 
Medicinal Chemistry

The Weizmann Institute of Science establishes the Dr. Barry Sherman Institute for Medicinal Chemistry

04.12.2018
Biochemistry, Disease, Drugs & Diagnostics, Chemistry, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs
The Institute will fund innovative research on compounds that hold promise for becoming therapies for a range of human diseases and...
Bruce Lefker and Berta Strulovici

Weizmann Institute of Science Announces Visiting Scientist Agreement with Pfizer Inc.

05.06.2016
Yeda Technology Transfer, Benefiting Humanity, Diagnostic Techniques and Drugs
The Weizmann Institute of Science in Rehovot, Israel, and Yeda Research and Development Co., Ltd., its commercial arm, announced this week that they...
(l-r) Osnat Tirosh, Nir Fluman and Prof. Eitan Bibi

Arms Race

29.11.2012
Biochemistry, Viruses & Microorganisms, Benefiting Humanity
Scientists reveal one of bacteria’s secret weapons against antibiotics
Alternative Energy Research Initiative (AERI)

New Grant to Fuel Solar Energy Research

24.10.2012
Particle Physics, Earth Sciences, Energy, Materials Science, Benefiting Humanity
The Helmsley Charitable Trust will fund joint research between the Weizmann Institute and the Technion
Prof. Amir Pnueli

Verifying correctness and reliability of computer hardware and software

25.11.2010
Math & Computer Science, Benefiting Humanity
Application      
Prof. Michael Sela

Copaxone® - MS medication

10.10.2010
Benefiting Humanity, Diagnostic Techniques and Drugs
from the institute to Teva Pharmaceuticals Ltd.
Prof. David Wallach

Anti-Inflammatory Compounds

12.09.2010
Biochemistry, Benefiting Humanity
The proteins identified by Prof. David Wallach are being used in clinical trials as anti-inflammatory compounds that may control rheumatoid...
Prof. Michel Revel

Interleukin-6

12.09.2010
Disease, Drugs & Diagnostics, Benefiting Humanity
 A drug developed  by InterPharm Laboratories Ltd. was first isolated and cloned by Prof. Michel Revel.
Prof. Yosef Shaul

Bio-Hep-B vaccine

12.09.2010
Genetics, Benefiting Humanity
Bio-Hep-B, a vaccine for hepatitis B based on Prof. Shaul's research, is produced by Biotechnology General and marketed in Israel

Pages

Top Stories

See All >
MRI image

CEST la vie: High-Powered Magnets Improve Early Detection of Cancer in Rats

Dr. Michal Leskes

Prof. Giora Mikenberg
Noam Stern-Ginossar and group

Host and Virus Face Off over RNA Modification

Press Releases
See All >
08.04.2019
New Clinical Study Being Launched at the Weizmann Institute of Science
E. Coli
27.03.2019
Same Microbe, Different Effect
21.03.2019
Historic partnership between the Weizmann Institute of Science and Institut Curie